Africa.com

Stay Smart About Africa

Is Africa Ready to Receive Mass Stocks of Vaccines?

152228087 - covid-19 corona virus syring vaccine

The announcement by American pharmaceutical giant Pfizer that it has developed a vaccine that interim analysis shows is 90% effective against Covid-19 marks a potential end to the pandemic but asks serious questions of Africa’s ability to administer the protection. The vaccine candidate developed with BioNTEch, which remains in trials, must be transported at -70 degrees celsius and stored in a low-temperature fridge for a maximum five days, leading to worries that Africa’s poor infrastructure will delay vaccinations or prevent them completely. According to the World Health Organization (WHO) at least 25% of vaccines are thrown away due to problems in cold chain logistics. The percentage could be higher for the Pfizer vaccine in Africa, where infrastructure is limited and around 60% of the population live in rural areas. Many African countries cannot afford to build the cold chain facilities needed, leading to fears that the vaccine will be more readily available in richer nations. Fears have also been expressed that African countries will not have the funds to procure sufficient vaccine doses when one becomes available.

SOURCE: AFRICAN BUSINESS MAGAZINE

We are committed to Africa
Will You Support Us?

Unlike many global publications, for nearly a decade we have been committed to showing a complete picture of Africa – not just a single story.  Offended by one-sided coverage of wars, disasters and disease, the founders of Africa.com created a website that provides a balanced view of Africa – current events, business, arts & culture, travel, fashion, sports, information, development, and more.
%d bloggers like this: